The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bakhiet, M.
Right arrow Articles by Olsson, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bakhiet, M.
Right arrow Articles by Olsson, T.

The Journal of Immunology, Vol 157, Issue 8 3518-3526, Copyright © 1996 by American Association of Immunologists


ARTICLES

Control of parasitemia and survival during Trypanosoma brucei brucei infection is related to strain-dependent ability to produce IL-4

M Bakhiet, L Jansson, P Buscher, R Holmdahl, K Kristensson and T Olsson
Molecular Medicine Unit, Department of Medicine, Karolinska Hospital, Stockholm, Sweden. Moiz.Bakhiet@cnsf.ki.se

We studied non-MHC gene-dependent expression of a number of cytokines in relation to host defense and survival during Trypanosoma brucei brucei (Tbb) infection in mice. In particular, the role of IL-4 was explored with use of genomically IL-4-disrupted mice and in vivo Ab blocking. Splenocytes from MHC-identical B10.Q (relatively resistant) mice showed day 5 postinfection higher numbers of IL-4 mRNA expressing cells than C3H.Q (highly susceptible). A trypanosome-derived lymphocyte triggering factor, which is released by Tbb to polyclonally activate CD8+ T cells, stimulated naive splenocytes in vitro to a higher IL-4 response in B10.Q than in C3H.Q mice. The C3H.Q mice developed an extremely high parasitemia, showed a low Ab response against the variant surface glycoprotein (VSG), and had a mean survival time of 42 days. Conversely, B10.Q mice had lower parasitemia, mounted higher anti- VSG response, and had a mean survival time of 56 days. Deletion of the IL-4 gene had no influence on the infection in C3H.Q mice, while in B10.Q mice the deletion was associated with lower anti-VSG Ab levels and higher parasitemia. Paradoxically, B10.Q mice with disrupted IL-4 gene survived longer than the wild type. Anti-IL-4 Ab-blocking experiments in vivo displayed an enhanced parasitemia and prolonged survival in infected B10.Q mice. We conclude that 1) a non-MHC gene- related and CD8+-dependent ability to produce IL-4 partly determines the susceptibility to Tbb infection; and 2) IL-4, although involved in controlling the levels of parasitemia by its effects on immunoglobulin synthesis, also can have toxic effects on the animals.


This article has been cited by other articles:


Home page
Infect. Immun.Home page
W. Noel, G. Hassanzadeh, G. Raes, B. Namangala, I. Daems, L. Brys, F. Brombacher, P. D. Baetselier, and A. Beschin
Infection Stage-Dependent Modulation of Macrophage Activation in Trypanosoma congolense-Resistant and -Susceptible Mice
Infect. Immun., November 1, 2002; 70(11): 6180 - 6187.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
M.-L. F. van Velthuysen and S. Florquin
Glomerulopathy Associated with Parasitic Infections
Clin. Microbiol. Rev., January 1, 2000; 13(1): 55 - 66.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. E. Uzonna, R. S. Kaushik, J. R. Gordon, and H. Tabel
Experimental Murine Trypanosoma congolense Infections. I. Administration of Anti-IFN-{gamma} Antibodies Alters Trypanosome-Susceptible Mice to a Resistant-Like Phenotype
J. Immunol., November 15, 1998; 161(10): 5507 - 5515.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
L. R. Schopf, H. Filutowicz, X.-J. Bi, and J. M. Mansfield
Interleukin-4-Dependent Immunoglobulin G1 Isotype Switch in the Presence of a Polarized Antigen-Specific Th1-Cell Response to the Trypanosome Variant Surface Glycoprotein
Infect. Immun., February 1, 1998; 66(2): 451 - 461.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.